Groups | P value | ||
---|---|---|---|
Control | FM | ||
Subject number (n) | 28 | 28 | - |
Age (years) | 42.5±7.6 | 42.1±10.6 | 0.886 |
Sex | 26F/2M | 26F/2M | - |
HADS total score (0–42) | 9.6±6.1 | 20.3±6.5 | <0.001* |
HADS anxiety score (0–21) | 4.6±3.4 | 11.6±3.5 | <0.001* <0.001* |
HADS depression score (0–21) | 3.6±3.1 | 8.7±3.8 | <0.001* |
Number of tender points (0–18) | 5.9±3.7 | 15.2±2.0 | <0.001* |
Total Tenderness Score (0–54) | 7.7±5.5 | 29.1±7.0 | <0.001* |
Clinical pain intensity (0–10) | - | 5.28±2.4 | - |
Disease duration (years) | - | 7.3±9.2 | - |
Widespread Pain Index (0–19) | - | 9.9±4.3 | - |
Symptom Severity (0–12) | - | 7.9±1.7 | - |
Revised Fibromyalgia Impact Questionnaire (0–100) | - | 50.6±20.6 | - |